Population pharmacokinetics and model-based dosing evaluation of bedaquiline in multidrug-resistant tuberculosis patients

Aims: Bedaquiline is now recommended to all patients in the treatment of multidrug-resistant tuberculosis (MDR-TB) using standard dosing regimens. As the ability to measure blood drug concentrations is very limited, little is known about drug exposure and treatment outcome. Thus, this study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales: Shao, Ge, Bao, Ziwei, Davies Forsman, Lina, Paues, Jakob, Werngren, Jim, Niward, Katarina, Schön, Thomas, Bruchfeld, Judith, Alffenaar, Jan-Willem, Hu, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083270/
https://www.ncbi.nlm.nih.gov/pubmed/37050904
http://dx.doi.org/10.3389/fphar.2023.1022090

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083270/
https://www.ncbi.nlm.nih.gov/pubmed/37050904
http://dx.doi.org/10.3389/fphar.2023.1022090

Ejemplares similares